International Childhood Cancer Day aims to spread awareness about childhood cancers. Childhood cancers (0-14 years of age) ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

Former Iowa Hawkeyes women's basketball player Ava Jones was forced to medically retire from the team in 2024. Now, there is ...

"Only a patient can really appreciate how much ringing the bell matters. So the day he hung it up, it was the most joyous ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

Brielle Robinson, of Kingman, was nearing her eighth birthday when her family noticed a lump on the left side of her neck.

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.